Givinostat
In Stock•Starting at $130 for 25 mg•Purity ≥ 99%
| CAS No. | 497833-27-9 |
|---|---|
| MDL No. | N/A |
| MF | C24H27N3O4 |
| MW | 421.50 |
| InChI Key | YALNUENQHAQXEA-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 25 mg | 99+% | $130 | In Stock | |
| 50 mg | 99+% | $219 | In Stock | |
| 100 mg | 99+% | $369 | In Stock | |
| 250 mg | 99+% | $698 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Givinostat is a naphthalene derivative substituted with ({[4-(hydroxycarbamoyl)phenyl]carbamoyl}oxy)methyl at position 2 and (diethylamino)methyl at position 6. It is a histone deacetylase inhibitor used in the treatment of Duchenne muscular dystrophy. It functions as an anti-inflammatory, angiogenesis inhibitor, antineoplastic agent, and apoptosis inducer. It is classified as a carbamate ester, tertiary amino compound, hydroxamic acid, and member of naphthalenes and benzenes. It is also the conjugate base of givinostat(1+).
| CAS No. | 497833-27-9 |
|---|---|
| Product Name | Givinostat |
Biological Targets
HDAC1·HDAC3·HDAC6·HDAC2·HDAC5·
Associated Conditions
polycythemia vera·Hodgkins lymphoma·Duchenne muscular dystrophy·Crohn's disease·Becker muscular dystrophy·
* The information provided here is compiled from public sources and is for reference only.
